Extensively Hydrolyzed Hypoallergenic Infant Formula with Retained T Cell Reactivity.
Raphaela FreidlVictoria GaribBirgit LinhartElisabeth M HaberlIsabelle MaderZsolt SzépfalusiKlara SchmidthalerNikos DouladirisAlexander PampuraEvgeniy VarlamovTatiana LepeshkovaEvgeny BeltyukovVeronika Victorovna NaumovaStyliani TakaDina NosovaOlga GuliashkoMichael KundiAlina KiyamovaStefani KatsamakiRudolf ValentaPublished in: Nutrients (2022)
Due to strongly reduced allergenic activity and induction of inflammatory cytokine secretion but retained T cell reactivity, the identified eHF may be used for treatment and prevention of CMA by induction of specific T cell tolerance.